Wangjing Hospital, China Academy of Chinese Medical Sciences
12
1
1
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 12 trials
100.0%
+13.5% vs industry average
17%
2 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Osteoporotic Vertebral Compression Fracture Cohort Study
Role: lead
Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia
Role: lead
Clinical Trial of Huoluo Pills Combined With Iguratimod Tablets in the Treatment of Rheumatoid Arthritis
Role: lead
Rotation-traction Manipulation of Different Treatment Frequency in Cervical Radiculopathy
Role: lead
The Study of Chinese Medicine for the Treatment of Primary Osteoporosis
Role: lead
The Study of Chinese Medicine for the Treatment of Chronic Atrophic Gastritis
Role: lead
Multicenter Cohort Study on Osteoporosis
Role: collaborator
Remote Ischemic Conditioning for Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage
Role: collaborator
Effect of Perioperative Lidocaine on Gastrointestinal Function Recovery After Lumbar Spine Surgery in Adults
Role: collaborator
Registration of the Study of Reyanning Mixture
Role: collaborator
A Registry Study of Shujinjianyao Pill Used in Clinical Real World
Role: collaborator
Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis
Role: collaborator
All 12 trials loaded